These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 7438147)

  • 1. Adriamycin-induced alterations of the action potential in rat papillary muscle.
    Lazarus ML; Rossner KL; Anderson KM
    Cardiovasc Res; 1980 Aug; 14(8):446-50. PubMed ID: 7438147
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Free radical involvement in doxorubicin-induced electrophysiological alterations in rat papillary muscle fibres.
    Venditti P; Balestrieri M; De Leo T; Di Meo S
    Cardiovasc Res; 1998 Jun; 38(3):695-702. PubMed ID: 9747437
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adriamycin stimulates low-affinity Ca2+ binding and lipid peroxidation but depresses myocardial function.
    Singal PK; Pierce GN
    Am J Physiol; 1986 Mar; 250(3 Pt 2):H419-25. PubMed ID: 3953836
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Postnatal developmental changes in the electrophysiological properties of cat right ventricular papillary muscles.
    Sheridan DJ
    Cardiovasc Res; 1980 Dec; 14(12):700-9. PubMed ID: 7260963
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Electrophysiological effects of OPC-88117, a new antiarrhythmic agent on papillary muscles and single ventricular myocytes isolated from guinea-pig hearts.
    Toyama J; Kodama I; Honjo H; Kamiya K
    Br J Pharmacol; 1989 Sep; 98(1):177-85. PubMed ID: 2553186
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cellular electrophysiological effect of terikalant in the dog heart.
    Biliczki P; Acsai K; Virág L; Tálosi L; Jost N; Biliczki A; Papp JG; Varró A
    Eur J Pharmacol; 2005 Mar; 510(3):161-6. PubMed ID: 15763239
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute negative inotropic effect of adriamycin (doxorubicin).
    Höfling B; Bolte HD
    Naunyn Schmiedebergs Arch Pharmacol; 1981 Nov; 317(3):252-6. PubMed ID: 7322214
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of the interaction of R 56865 with cardiac Na- and L-type Ca channels.
    Wilhelm D; Himmel H; Ravens U; Peters T
    Br J Pharmacol; 1991 Oct; 104(2):483-9. PubMed ID: 1665739
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of gallium chloride on changes in action potentials and contraction in guinea pig ventricular muscle.
    Kantelip JP; Millart H; Leperre A; Mougin F; Didier JM
    Anticancer Res; 1996; 16(1):327-32. PubMed ID: 8615630
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of 5-(N,N-hexamethylene)amiloride on action potentials, intracellular Na, and pH of guinea pig ventricular muscle in vitro.
    Lai ZF; Hotokebuchi N; Cragoe EJ; Nishi K
    J Cardiovasc Pharmacol; 1994 Feb; 23(2):259-67. PubMed ID: 7511756
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiarrhythmic-like actions of the smooth muscle spasmolytic agent, cinnamedrine, on action potentials of mammalian ventricular tissue.
    Arena JP; McArdle JJ; Argentieri TM
    Pharmacology; 1987; 34(5):286-95. PubMed ID: 3615570
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of the effects of the new inotropic agent BDF 9148 in isolated papillary muscles and myocytes of the guinea-pig heart.
    Ravens U; Wettwer E; Pfeifer T; Himmel H; Armah B
    Br J Pharmacol; 1991 Dec; 104(4):1019-23. PubMed ID: 1667282
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Electrophysiological effects of Org 7797 in the closed-chest anaesthetized dog.
    Leboeuf J; Basiez M; Massingham R
    Br J Pharmacol; 1993 Sep; 110(1):23-8. PubMed ID: 8220882
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of elevated extracellular potassium concentrations on the class III antiarrhythmic action of sotalol.
    Cobbe SM; Manley BS
    Cardiovasc Res; 1985 Feb; 19(2):69-75. PubMed ID: 3978667
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differences in the effects of urinary incontinence agents S-oxybutynin and terodiline on cardiac K(+) currents and action potentials.
    Jones SE; Shuba LM; Zhabyeyev P; McCullough JR; McDonald TF
    Br J Pharmacol; 2000 Sep; 131(2):245-54. PubMed ID: 10991917
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blockade of 2,4-dinitrophenol induced ATP sensitive potassium current in guinea pig ventricular myocytes by class I antiarrhythmic drugs.
    Wu B; Sato T; Kiyosue T; Arita M
    Cardiovasc Res; 1992 Nov; 26(11):1095-101. PubMed ID: 1291087
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Direct effects of hydralazine on cardiac contractile function, haemodynamics, and myocardial energetics in isolated myocardium.
    Rendig SV; Segel LD; Amsterdam EA
    Cardiovasc Res; 1988 May; 22(5):322-8. PubMed ID: 3191517
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibitory actions of amoxapine, a tricyclic antidepressant agent, on electrophysiological properties of mammalian isolated cardiac preparations.
    Kinugawa T; Kotake H; Mashiba H
    Br J Pharmacol; 1988 Aug; 94(4):1250-6. PubMed ID: 3207983
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The antiarrhythmic and cardiac electrophysiological effects of buprenorphine.
    Boachie-Ansah G; Sitsapesan R; Kane KA; Parratt JR
    Br J Pharmacol; 1989 Jul; 97(3):801-8. PubMed ID: 2758241
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Electrophysiological effects of AFD-21 and AFD-19, new antiarrhythmic compounds on papillary muscles and single ventricular myocytes isolated from guinea-pig hearts.
    Kodama I; Kamiya K; Kawamura T; Suzuki R; Toyama J
    Br J Pharmacol; 1990 Dec; 101(4):803-8. PubMed ID: 2085705
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.